Dr Gillinder Bedi is a Senior Research Fellow at Orygen and the University of Melbourne, and a clinical psychologist. She joined Orygen in 2017 to lead the development of a substance use research program.
Gill completed graduate training in clinical psychology at Monash University in Melbourne, Australia, investigating cognitive function and mood in ecstasy and cannabis users. Her postdoctoral research, which focused on characterising the acute effects of MDMA (ecstasy) in humans, was undertaken at the University of Chicago. From 2009 until 2017, she was a faculty member in the Division on Substance Use Disorders at Columbia University Medical Center/New York State Psychiatric Institute in NYC.
Gill’s research focuses on emerging substance use disorders in young people, experimental medicine models of drug use and misuse, and neurobehavioral processes contributing to the onset and maintenance of substance use disorders. She uses a range of range of research methods including human behavioural pharmacology and neuroimaging (MRI).